Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems (Q45059018)

9 December 2017

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems (English)

1 reference

9 December 2017

0 references

0 references

0 references

Wei Xiang

1

1 reference

9 December 2017

Juan Kong

2

1 reference

9 December 2017

Songcang Chen

3

1 reference

9 December 2017

Li-Ping Cao

4

1 reference

9 December 2017

Guilin Qiao

5

1 reference

9 December 2017

Wei Zheng

6

1 reference

9 December 2017

Wenhua Liu

7

1 reference

9 December 2017

Xinmin Li

8

1 reference

9 December 2017

David G Gardner

9

1 reference

9 December 2017

Yan Chun Li

10

1 reference

9 December 2017

14 September 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

9 December 2017

1 reference

9 December 2017

288

1 reference

9 December 2017

E125-32

1 reference

9 December 2017

1

1 reference

Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system

9 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Ontogenesis of the vitamin D receptor in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

The involvement of the endocrine system in regulating cardiovascular function: emphasis on vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Vitamin D3 and cardiovascular function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00224.2004

10.1152/AJPENDO.00224.2004

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference